TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
+6.36%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$161M
AUM Growth
+$161M
(-4.9%)
Cap. Flow
-$13.3M
Cap. Flow
% of AUM
-8.21%
Top 10 Holdings %
Top 10 Hldgs %
73.42%
Holding
44
New
6
Increased
7
Reduced
10
Closed
9
Top Buys
| 1 |
Medtronic
MDT
|
$9.33M |
| 2 |
NUVA
NuVasive, Inc.
NUVA
|
$8.87M |
| 3 |
QuidelOrtho
QDEL
|
$6.58M |
| 4 |
CVS Health
CVS
|
$6.1M |
| 5 |
SRCL
Stericycle Inc
SRCL
|
$4.51M |
Top Sells
| 1 |
SPNC
Spectranetics Corp
SPNC
|
$10.2M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$8.55M |
| 3 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$6.19M |
| 4 |
Brookdale Senior Living
BKD
|
$4.78M |
| 5 |
Lantheus
LNTH
|
$4.54M |
Sector Composition
| 1 | Healthcare | 93.57% |
| 2 | Industrials | 6.43% |
| 3 | Consumer Discretionary | 0% |
| 4 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
1
DELISTED
Veradigm Inc. Common Stock
MDRX
| $21M | 12.85% | 1,475,000 +225,000 | +18% | +$3.2M |
|
2
NovoCure
NVCR
$1.38B
| $14.8M | 9.04% | 743,554 -161,446 | -18% | -$3.2M |
|
3
Nektar Therapeutics
NKTR
$568M
| $13.2M | 8.08% | 550,000 -40,000 | -7% | -$960K |
|
|
4
Medtronic
MDT
$119B
| $12.8M | 7.86% | 165,000 +120,000 | +267% | +$9.33M |
|
|
CORI
5
DELISTED
Corium International, Inc.
CORI
| $10.5M | 6.44% | 950,000 -25,000 | -3% | -$277K |
|
6
Gilead Sciences
GILD
$140B
| $10.1M | 6.2% | 125,000 -10,000 | -7% | -$810K |
|
7
Pacira BioSciences
PCRX
$1.2B
| $9.39M | 5.75% | 250,000 +35,000 | +16% | +$1.31M |
|
8
Labcorp
LH
$23.1B
| $9.06M | 5.55% | 60,000 -8,000 | -12% | -$1.21M |
|
|
NUVA
9
DELISTED
NuVasive, Inc.
NUVA
| $8.87M | 5.43% | +160,000 | New | +$8.87M |
|
|
SRCL
10
DELISTED
Stericycle Inc
SRCL
| $8.81M | 5.39% | 123,000 +63,000 | +105% | +$4.51M |
|
|
11
QuidelOrtho
QDEL
$1.95B
| $6.58M | 4.03% | +150,000 | New | +$6.58M |
|
12
Steris
STE
$24.1B
| $6.19M | 3.79% | 70,000 -15,000 | -18% | -$1.33M |
|
|
13
CVS Health
CVS
$92.8B
| $6.1M | 3.73% | +75,000 | New | +$6.1M |
|
|
HIND
14
Vyome Holdings, Inc. Common Stock
HIND
$243M
| $5.22M | 3.19% | 547,536 +19,470 | +4% | +$186K |
|
|
CORV
15
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $3.73M | 2.28% | 1,750,000 -50,000 | -3% | -$107K |
|
16
Dentsply Sirona
XRAY
$2.85B
| $2.99M | 1.83% | 50,000 -27,000 | -35% | -$1.62M |
|
|
17
Lantheus
LNTH
$3.73B
| $2.31M | 1.42% | 130,000 -255,000 | -66% | -$4.54M |
|
18
AtriCure
ATRC
$1.84B
| $2.24M | 1.37% | +100,000 | New | +$2.24M |
|
|
ISEE
19
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.19M | 1.34% | 775,000 +150,000 | +24% | +$423K |
|
|
RCM
20
DELISTED
R1 RCM Inc. Common Stock
RCM
| $1.58M | 0.97% | 425,000 +175,000 | +70% | +$649K |
|
|
STRM
21
DELISTED
Streamline Health Solutions
STRM
| $1.54M | 0.94% | 1,046,666 -91,334 | -8% | -$134K |
|
22
Evolent Health
EVH
$1.12B
| $1.34M | 0.82% | +75,000 | New | +$1.34M |
|
|
SIEN
23
DELISTED
Sientra, Inc.
SIEN
| $924K | 0.57% | +60,000 | New | +$924K |
|
24
Alkermes
ALKS
$4.78B
| – | – | -30,000 | Closed | -$1.74M |
|
25
Baxter International
BAX
$12.7B
| – | – | 0 | – | – |
|